Positioned high-profile pharmaceutical companies to outpace competitors through complex, transformative change initiatives, closing profitability gaps from –16% to +20% across Fortune 100 divisions and delivering $42M in EBITDA gains within five years. Responsible for building a medical portfolio from the ground up, including the acquisition of 40 healthcare practices, surgical centers, and multiple billing and EMR organizations. Oversaw the successful transition of six CEOs

Led post-merger integration of acquired entities, including consolidation of financial operations. Established optimized banking and investment structures projected to generate additional interest income. Managed monthly compensation and payment processes for a large network of contracted physicians and leased facilities across multiple locations. As Interim CFO, converted financials from cash to accrual, established a corporate card program generating over $500K in funding,

Lead global marketing strategy to strengthen brand presence, drive market expansion, and accelerate growth across a diverse portfolio of plasmid DNA, mRNA, proteins, and other key components supporting gene and cell therapy, vaccines, and diagnostics. Partner with commercial, product, and R&D teams to deliver customer-focused campaigns, elevate thought leadership, and advance a data-driven marketing transformation that enables groundbreaking science and team excellence Execut

Built the FP&A function from the ground up, reporting directly to the CFO, creating financial models for budgeting, forecasting, scenario planning, and new product ventures, while managing direct reports. Developed and implemented a 13-week cash flow model and integrated SaaS revenue model combining three legacy businesses to improve forecasting accuracy and financial visibility. Implemented Jirav FP&A software integrated with NetSuite, creating monthly reporting packages, da